ClinicalTrials.gg
RecruitingNCT07040215Updated Jun 27, 2025

Effects on Subacute Stroke With Robotic Assistive Gait Training

An interventional study of Freewalk lower limb Robotic Assistive Gait Training and Physiotherapy in Stroke and Stroke Gait Rehabilitation, sponsored by Changhua Christian Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 45 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-06-27.

Sponsored by Changhua Christian Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
45 Years to 70 Years
Sex
All
01

Study summary

The goal of this randomized controlled trial is to learn about the effects of Robotic Assisted Gait Training (RAGT) combined with traditional physical therapy in subacute stroke patients. The main question it aims to answer is:

- Does RAGT combined with traditional physical therapy improve gait and functional performance in subacute stroke patients compared to traditional physical therapy alone? Participants who are subacute stroke patients will be randomly assigned to receive either both RAGT and traditional physical therapy or only traditional physical therapy. Their gait and functional performance will be assessed during the study period.

Read the detailed description

The sequelae of stroke have a significant impact on patients' physical functions and quality of life. Although traditional physical therapy can help some patients regain function, its effectiveness is often limited. Therefore, exploring new rehabilitation technologies has become one of the key tasks in the medical field. Robotic Assisted Gait Training (RAGT) is an emerging technology that provides high-intensity and repetitive gait training, making it particularly suitable for patients in the post-stroke rehabilitation phase. Recent studies have shown that RAGT can significantly improve gait abilities in stroke patients, including walking speed and functional performance. Therefore, this study will adopt a randomized controlled trial design, recruiting 20 subacute stroke patients who will be randomly assigned to either a group receiving both RAGT and traditional physical therapy or a group receiving only traditional physical therapy. The study will compare differences in gait and functional performance between the two groups during the rehabilitation process, aiming to provide a foundation for future personalized and precision treatment plans.

02

Conditions studied

  • Stroke
  • Stroke Gait Rehabilitation

Browse trials for

Keywords

  • physiotherapy
  • Robotic Assistive Gait Training
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's planned enrollment of 40 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Changhua Christian Hospital is the lead sponsor of 76 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with stroke (ischemic or hemorrhagic) confirmed by medical imaging.
  • Subacute phase of stroke (onset within 1 to 3 months).
  • Moderate to good standing balance ability.
  • Sufficient cognitive ability to understand the study and follow instructions.
  • Able to participate in rehabilitation training during the study period.

Exclusion criteria

Exclusion Criteria:

  • Body weight over 90 kg.
  • Presence of other neurological disorders.
  • Severe cardiovascular disease or other health conditions affecting mobility.
  • Significant lower limb pain, joint contracture, or spasticity (Modified Ashworth Scale score > 3) that impairs walking.
  • Diagnosed with cardiopulmonary disease that contraindicates exercise training.
  • Cognitive impairment that prevents understanding of training instructions or completion of questionnaires.
  • Inability to complete the rehabilitation training protocol.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Active comparator
    Conventional PT

    Conventional Physiotherapy

    Other: Physiotherapy

  • Experimental
    Robotic Gait Training

    Conventional Physiotherapy combined with Robotic Assistive Gait Training

    Device: Freewalk lower limb Robotic Assistive Gait Training · Other: Physiotherapy

Interventions

  • DeviceFreewalk lower limb Robotic Assistive Gait Training

    Participants in this group will receive robotic-assisted gait training three times per week (every other day) for 30 minutes per session, using the FREE Walk exoskeleton device (FREE Bionics, Taiwan). The device assists with walking, standing, and sitting. A physical therapist will help the participant wear the exoskeleton and supervise the training, adjusting the level of robotic support and intensity based on the participant's ability. In addition to RAGT, participants will receive conventional stroke rehabilitation therapy (including sit to stand, balance and gait training) on the remaining weekdays (2 days/week), 30 minutes per session. Intervention Duration: 4 weeks.

  • OtherPhysiotherapy

    Participants in this group will receive conventional stroke rehabilitation therapy (including sit to stand, balance and gait training) 5 days/week, 30 minutes per session. Intervention Duration: 4 weeks.

06

What researchers measure

Primary outcomes

  1. Gait Speed

    Gait speed will be calculated as distance divided duration. A timer will collect the duration (seconds, s) while subjects walk 3 meters (m, distance). The gait speed showed as (m/s) directly.

    Time frame: Baseline and after 4 weeks of intervention

  2. Step Length

    Objective assessment of gait performance using two inertial sensors attached to the shoes. Measures include step length (meters)

    Time frame: Baseline and after 4 weeks of intervention

  3. Toe Clearance

    Objective assessment of gait performance using two inertial sensors attached to the shoes. Measures include toe clearance (meters).

    Time frame: Baseline and after 4 weeks of intervention

  4. Timed Up and Go Test (TUG)

    Assesses functional mobility and fall risk. Participants stand up from a chair, walk 3 meters, turn around, return, and sit down. The time taken to complete the task is recorded.

    Time frame: Baseline and after 4 weeks of intervention

  5. Functional Independence Measure (FIM)

    Evaluates the level of a participant's independence in daily activities. The FIM includes 18 items across motor and cognitive domains, each scored from 1 (total assistance) to 7 (complete independence), with a total score range of 18 to 126.

    Time frame: Baseline and after 4 weeks of intervention

Secondary outcomes

  1. Berg Balance Scale (BBS)

    Assesses participants' static and dynamic balance abilities using a 14-item scale. Each item is scored from 0 to 4, with a total score ranging from 0 to 56. Higher scores indicate better balance.

    Time frame: Baseline and after 4 weeks of intervention

  2. 30-Second Chair Stand Test (30-CST)

    Measures lower limb strength and endurance. Participants are asked to stand up and sit down from a standard chair as many times as possible within 30 seconds, with arms crossed over the chest.

    Time frame: Baseline and after 4 weeks of intervention

  3. Surface Electromyography (sEMG)

    Non-invasive recording of muscle activity during walking using adhesive electrodes placed on major lower limb muscles (e.g., quadriceps, tibialis anterior, gastrocnemius).

    Time frame: Baseline and after 4 weeks of intervention

  4. Short Form-12 Health Survey (SF-12)

    Self-reported measure of health-related quality of life. Includes 12 questions covering 8 domains such as physical functioning, role limitations, pain, general health, vitality, social functioning, emotional role, and mental health.

    Time frame: Baseline and after 4 weeks of intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07040215
Lead sponsor
Changhua Christian Hospital
Responsible party
Sponsor
First posted
Jun 27, 2025
Start date
Jul 1, 2025 (estimated)
Primary completion
Apr 30, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
Jun 27, 2025

Study contacts

Office of Human Subject Protection Changhua Christian Hospital
Contact
d9010@cch.org.tw
886-4-7238595 ext. 8377
Su-Fen Liao
principal investigator · Changhua Christian Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion